Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate

Actinic keratosis (AK) is a precancerous skin lesion that is common in HIV-positive patients. Without effective treatment, AKs can progress to squamous cell carcinoma. Ingenol mebutate, a PKC agonist, is a US Food and Drug Administration–approved (FDA-approved) topical treatment for AKs. It can indu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCI Insight
Autors principals: Jiang, Guochun, Maverakis, Emanual, Cheng, Michelle Y., Elsheikh, Maher M., Deleage, Claire, Méndez-Lagares, Gema, Shimoda, Michiko, Yukl, Steven A., Hartigan-O’Connor, Dennis J., Thompson, George R., Estes, Jacob D., Wong, Joseph K., Dandekar, Satya
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483647/
https://ncbi.nlm.nih.gov/pubmed/30944245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.126027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars